The neurokinin-1 and neurokinin-2 receptor binding sites of MDL103,392 differ

Scott Greenfeder, John C. Anthes(Centre for Inflammation Research), Robert W. Egan(AIL Research (United States)), Boonlert Cheewatrakoolpong(Merck & Co., Inc., Rahway, NJ, USA (United States)), Elizabeth Keene, Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Motasim Billah(Centre for Inflammation Research)
Bioorganic & Medicinal Chemistry
December 1, 1999
10.1016/s0968-0896(99)00220-5
Cited by 14

Related Papers

Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
|Science|2004|1.8k
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness
|Nature|2002|1.1k
Critical Assessment of Metagenome Interpretation—a benchmark of metagenomics software
|Nature Methods|2017|970
The regulation and cellular functions of phosphatidylcholine hydrolysis
|Biochemical Journal|1990|851
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502